FDA Inspection 1112129 — LifeShare Blood Center
The FDA completed an inspection of LifeShare Blood Center on Nov 19, 2019 in Bossier City, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 19, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bossier City, LA (United States)